This proven effectiveness comes from the lens’s novel RingBoost technology, which utilises non co-axial optics to create myopic retinal defocus and help manage myopia without compromising visual quality. More than 95% of children wearing Abiliti 1-Day achieved visual acuity of 6/6 or better.^§4 (Fig 1). “Most multifocal or dual focus style lenses are limited in the amount of plus that can be incorporated into the treatment zone as the ADD power is focused on the line of sight. Abiliti 1-Day’s non coaxial optics focus OFF the line of sight. This means we can have +7D in the treatment ring and a +10D central boost to maximise the myopia management effect,” said Dr Emma Gillies, J&J’s Head of Professional Education.

Fig 1. Effectiveness comes from the lens’s novel RingBoost technology, which utilises non co-axial optics to create myopic retinal defocus and help manage myopia without compromising visual quality.

Fit, comfort designed for kids

The lenses were also specifically designed for the paediatric eye, with a small diameter for easy insertion and removal^‡5, but made from the same silicone hydrogel material, senofilcon A, as Acuvue Oasys 1-Day, which have never been beaten in comfort in six clinical studies posted on ClinicalTrials.gov^μ.

In a randomised, controlled, crossover study:

1. 90.8% of kids reported they never or rarely could feel the lens on their eyes while wearing Abiliti 1-Day, compared to 69.7% for MiSight 1 Day^†1
   
   
2. 89.2% of kids agreed the Abiliti 1-Day lens was easy to put in the eyes, compared to 53% for MiSight 1 Day^†1
   
   
3. 93.8% of kids agreed that Abiliti 1-Day lens were easy to take out of the eyes, compared to 77.3% for MiSight 1 Day lens^†1
   
   
4. 95.4% of kids reported they never or rarely experienced Abiliti 1-Day lens moving out of place or falling out, compared to 66.7% for MiSight 1 Day lens^†1.
   
   

Compared to spectacles, wearing contact lenses also boosted kids’ self-confidence and improved both their school and sports performance^6,7. “Contact lens wear dramatically improves how children and teens feel about their appearance and participation in activities, leading to greater satisfaction with their refractive error correction,” concluded lead author Dr Jeffery Walline, Associate Dean, Ohio State University’s College of Optometry, in his study⁷.

“The lenses are made from senofilcon A material, which is easy to handle and very comfortable. Optometrists who are fitting the lenses tell us that children are finding insertion and removal of the lenses very easy, which means a less stressful start to the day for both the kids and the parents! Because the lenses are so comfortable, children are wearing the lens for longer during the day. The only intervention that works is the one that the child actually wears, a comfortable material leads to better compliance,” said Dr Gillies.

“The 3 year clinical trial results are very exciting and we are delighted to help optometrists confidently fit this revolutionary new design, confident in the knowledge that they can slow their patients’ myopia progression with a comfortable and easy-to-handle contact lens.”

For more…

To add Abiliti 1-Day to your myopia management toolkit and access educational materials and expert support, visit JNJVISIONPRO – a go-to resource for eyecare professionals. Complete the Acuvue Abiliti 1-Day Accreditation Program on JNJVISIONPRO or contact your local J&J representative.

Footnotes
* Based on spherical equivalent of cycloplegic auto refraction change ≥-0.25 D, from 3-year outcome of a pivotal clinical trial.
¥ Based on publicly available information as of December 3, 2021.
** Senofilcon A prototype dual focus lens, based on axial elongation data from a 6-month clinical trial.
^ Compared to a single vision contact lens, based on 3-year outcome of a pivotal clinical trial.
§ Measured using LogMAR visual acuity where 0.00 LogMAR is equivalent to 6/6 vision.
‡ Utilizing a smaller lens diameter designed to fit the smaller anatomical features of a pediatric population (aged 7-12).
μ ClinicalTrials.gov is a website maintained by the NIH. The 6 clinical studies evaluated subjective comfort as a primary or secondary endpoint for ACUVUE® OASYS 1-Day with HydraLuxe® Technology Brand family contact lenses vs. competitors’ products. Review conducted as of October 31, 2025.
† Based on descriptive summaries of top-2-box (Never/Rarely) responses at 2 weeks in a randomized, controlled, crossover study (n = 75; intention-to-treat population; ages 7-17 years with sphere refraction: -1.00to -4.50 D, with ≤ 0.75 D astigmatism in each eye).

References

1.    JJV Data on File.
2.    JJV Data on File 2021. Development of Optical Design of ACUVUE Abiliti 1-Day Soft Therapeutic Lenses for Myopia Management.
3.    Cheng X, Xu J, Brennan NA. Randomized Trial of Soft Contact Lenses with Novel Ring Focus for Controlling Myopia Progression. Ophthalmol Sci. 2022;3(1):100232.
4.    JJV Data on File 2021. Stand-Alone Performance Claims - ACUVUE® Abiliti® 1-Day Soft Therapeutic Lenses for Myopia Management.
5.    JJV Data on File 2021. Mechanical Design of ACUVUE Abiliti 1-Day Soft Therapeutic Lenses for Myopia Management - Effect on Fit and Handling.
6.    Rah MJ, et al; ACHIEVE Study Group. Optom Vis Sci. 2010.
7.    Walline JJ, et al. Eye Contact Lens. 2007.